CHINA
N20
Manufacturer
API Contract Manufacturing, Exclusive Synthesis of API’s, Advanced Intermediates
Company Logo
Anhui Poly Pharmaceutical Co., Ltd., founded in September 2018, was invested by Hainan Poly Pharmaceutical Co., Ltd. (stock: 300630). As the first raw material and preparation integration project in Anqing City and Anhui Province built according to the international standards of China, the United States and the European Union, Anhui Poly Pharm. Co., Ltd.’s international high-end raw materials and innovative preparation manufacturing base integrates chemical drugs, biological enzymes and biological drugs. The project covers an area of about 300 mu (200,000 m2), with a total investment of 2.5 billion yuan. When the project is put into operation, the expected output value is about 3 billion yuan, with an annual tax revenue of 200 million yuan. The first phase of the project was put into operation in September 2021.